clinical trials

By  Skip Fleshman 11:19 am January 22, 2021
Clinical trials have become big news this year amid the search for COVID-19 vaccines and treatments. They are a critical component of helping the FDA validate that new drugs and diagnostics will be both safe and effective. Pharmaceutical companies spend over $45B a year running clinical trials, which are, by design, very methodical and measured. Unfortunately, they are also slow, unpredictable...
Theolytics, Oncolytics
By  Sara Mageit 05:54 am January 12, 2021
Oxford-based biotech company, Theolytics has announced the closing of a US $6.8 million (£5 million) Series A round. The round was co-led by Epidarex Capital and Taiho Ventures LLC with participation from existing investor, Oxford Sciences Innovation (OSI). The financing will be used to progress the company’s pipeline of candidates towards human clinical trials. WHY IT MATTERS Theolytics will...
Pharma, machine learning, medical devices

Credit: BGU

By  Rachel McArthur 11:20 am October 22, 2020
A new platform aimed at streamlining clinical trials in order to lower costs – and increase the efficiency and success rate of a drug or the development of a medical device – has been unveiled by Ben-Gurion University of the Negev (BGU). The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors including...

Credit: Panthera's Manchester site 

By  Sara Mageit 07:05 am October 8, 2020
UK-based independent SMO, Panthera Biopartners has completed a Series A funding round with Gresham House Ventures as a major investor. WHY IT MATTERS Panthera is looking to extend its UK site network by opening a new clinic in Glasgow and expanding existing locations to service higher patient volumes and take forward alliance partnerships across Europe. The Series A funding will also ensure...
By  Sara Mageit 01:48 am September 3, 2020
UK-based data capture software company, uMotif, has raised £5 million in a Series A investment round led by existing investor AlbionVC. The funding will accelerate uMotif’s growth and enable further development of its patient-centric and decentralised approach to clinical studies and enable expansion into new study types and more high-demand territories. WHY IT MATTERS Life sciences companies...
By  Laura Lovett 04:03 pm June 25, 2020
Historically, women have been underrepresented in clinical trials, however, that paradigm is changing. This shift is mainly due to policy changes in the last three decades, but today many innovators are also seeing a role for tech to play in closing this gap.  This morning MobiHealthNews sat down with a panel at Women of Wearables’ FemTech Forum to moderate a discussion about the gender gap in...
By  Dave Muoio 03:00 pm December 5, 2019
The FDA and National Institutes of Health are tapping the clinical community and a newly launched mobile platform in its search for novel infectious disease interventions. Called CURE ID, the online data repository will allow clinicians to report instances in which existing FDA-approved drugs are used to successfully treat infections. In particular, the tool captures clinical outcomes in cases...
By  Jonah Comstock 03:22 pm October 14, 2019
Atlanta-based Florence Healthcare, a maker of software for clinical trials, has raised $7.1 million in a Series B funding round led by Fulcrum Equity Partners, with additional participation from Atrium Health and Bee Partners. The round brings the company's total funding to at least $8.8 million, with a $1.7 million seed round from 2016. WHAT THEY DO Not to be confused with the UK social care...
By  Laura Lovett 01:18 pm October 1, 2019
Novartis is teaming up with Microsoft on a new artificial intelligence initiative focused on drug discovery and development. The new efforts will primarily be focused in Novartis’ newly announced AI innovation lab.  As part of the deal Novartis will be employing Microsoft’s AI tools to help its scientist with computational hurdles in life sciences including generative chemistry, image...
By  Dave Muoio 11:47 am July 29, 2019
Last week, Eko Devices announced a new service that matches ECG and heart sound recordings with clinical data to help pinpoint novel drug-data combinations. The Silicon Valley startup is pitching the platform, called Eko Home, as a resource for clinical trials targeting new therapies. The new platform is already seeing some action. According to the company, an ongoing Mayo Clinic study exploring...